Sign in

    Russell Yuan

    Research Analyst at William Blair

    Russell Yuan is an Equity Research Analyst at William Blair, focusing on the healthcare and life sciences sectors with specific coverage including companies like Zoetis Inc. Known for in-depth sector specialization, he has provided research-driven insights by participating in earnings calls and posing targeted questions to senior management of covered firms. Yuan began his career in equity research and joined William Blair prior to 2025, building a solid track record of sector expertise; performance metrics specific to his individual recommendations or formal TipRanks rankings are not publicly available. He holds the necessary professional credentials and securities licenses required for equity research analysts at major investment banks, ensuring compliance with FINRA regulatory standards.

    Russell Yuan's questions to Zoetis (ZTS) leadership

    Russell Yuan's questions to Zoetis (ZTS) leadership • Q4 2024

    Question

    Russell Yuan, on for Brandon Vazquez, asked for a high-level perspective on pet population trends post-COVID and whether any lagging macroeconomic effects are impacting the market.

    Answer

    CEO Kristin Peck responded that the pet population is expected to remain relatively stable, consistent with historical norms. She emphasized that the fundamental industry growth driver is the strengthening human-animal bond, which makes animal health resilient. She also noted that pets adopted during the pandemic are now aging, which is expected to increase demand for chronic care treatments.

    Ask Fintool Equity Research AI